Page 2 - கேரி மொத்த News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேரி மொத்த. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேரி மொத்த Today - Breaking & Trending Today

Countries often lack access to medicines and vaccines they help develop


By Mike Cummings
May 5, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
(© stock.adobe.com)
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.
The study, published May 5 in JAMA Network Open, covers 34 novel drugs sponsored by large pharmaceutical companies that the U.S. Food and Drug Administration (FDA) approved between 2012 and 2014. Approvals were made on the basis of a total of 898 trials that were held in the United States and 70 other countries worldwide. ....

South Africa , United States , Peter Bach , Nordrhein Westfalen , Cary Gross , Jennifer Miller , Bioethics International , Outcomes At Memorial Sloan Kettering Cancer Center , Yale School Of Medicine , Drug Administration , Yale School , Policy Outcomes , Memorial Sloan Kettering Cancer Center , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் பாக் , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , கேரி மொத்த , ஜெனிபர் மில்லர் , உயிர்வேதியியல் சர்வதேச , யேல் பள்ளி ஆஃப் மருந்து , யேல் பள்ளி , பாலிஸீ ஔட்கம்ஸ் , நினைவகம் ஸ்லோன் கெட்டரிங் புற்றுநோய் மையம் ,

Benefits of drug research are not being shared equitably among study participants, indicates study


Benefits of drug research are not being shared equitably among study participants, indicates study
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.
The study, published May 5 in
JAMA Network Open, covers 34 novel drugs sponsored by large pharmaceutical companies that the U.S. Food and Drug Administration (FDA) approved between 2012 and 2014. Approvals were made on the basis of a total of 898 trials that were held in the United States and 70 other countries worldwide. ....

South Africa , United States , Peter Bach , Nordrhein Westfalen , Cary Gross , Jennifer Miller , Emily Henderson , Bioethics International , Outcomes At Memorial Sloan Kettering Cancer Center , Yale School Of Medicine , Study Co , Drug Administration , Yale School , Study Co Author , Policy Outcomes , Memorial Sloan Kettering Cancer Center , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் பாக் , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , கேரி மொத்த , ஜெனிபர் மில்லர் , எமிலி ஹென்டர்சன் , உயிர்வேதியியல் சர்வதேச , யேல் பள்ளி ஆஃப் மருந்து , படிப்பு இணை , யேல் பள்ளி ,